Swartz R D
Nephron. 1981;28(2):65-9. doi: 10.1159/000182111.
The risk of worsening or commencement of bleeding in high-risk patients requiring hemodialysis has not been established. The present study of 300 dialyses in 51 patients with prospectively assessed increased risk for bleeding describes a method for limiting heparin administration by using the thrombin clotting time to assess heparin sensitivity before dialysis and to monitor heparin levels during dialysis. The procedure prevented clotting in the extracorporeal device and limited bleeding complications to 5% of cases overall. Patients with a higher risk for hemorrhage had a higher incidence of bleeding complication (26%), a larger fall in hematocrit, and more frequent requirement for blood replacement. We conclude that although hemodialysis poses a risk for actively bleeding patients, patients at risk but without active bleeding can be dialyzed with strict control of heparin administration.
需要进行血液透析的高危患者出血情况恶化或开始出血的风险尚未明确。本研究对51例经前瞻性评估出血风险增加的患者进行了300次透析,描述了一种通过使用凝血酶凝血时间在透析前评估肝素敏感性并在透析期间监测肝素水平来限制肝素给药的方法。该程序可防止体外装置凝血,并将出血并发症限制在总体病例的5%。出血风险较高的患者出血并发症发生率更高(26%),血细胞比容下降幅度更大,输血需求更频繁。我们得出结论,虽然血液透析对有活动性出血的患者构成风险,但对于有风险但无活动性出血的患者,可以在严格控制肝素给药的情况下进行透析。